Xiao-hua D. Yu
Haikou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
CTRP12 in cardiovascular and metabolic diseases: current status and future perspective.
Journal: Frontiers in cardiovascular medicine
Published: November 19, 2025
Gut microbiota-derived metabolite phenylacetylglutamine in cardiovascular and metabolic diseases.
Journal: Pharmacological research
Published: March 17, 2025
The m7G methylation modification: An emerging player of cardiovascular diseases.
Journal: International journal of biological macromolecules
Published: November 27, 2024
Indole-3-Carboxaldehyde Inhibits Inflammatory Response and Lipid Accumulation in Macrophages Through the miR-1271-5p/HDAC9 Pathway.
Journal: Journal of cellular and molecular medicine
Published: August 10, 2024
TNFAIP1 promotes macrophage lipid accumulation and accelerates the development of atherosclerosis through the LEENE/FoxO1/ABCA1 pathway.
Journal: Journal of physiology and biochemistry
Published: September 13, 2023
CTRP1: A novel player in cardiovascular and metabolic diseases.
Journal: Cytokine
Published: October 27, 2022
ABCA1, ABCG1, and Cholesterol Homeostasis.
Journal: Advances in experimental medicine and biology
Published: May 16, 2022
CORRIGENDUM: MicroRNA-182 Promotes Lipoprotein Lipase Expression and Atherogenesisby Targeting Histone Deacetylase 9 in Apolipoprotein E-Knockout Mice.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: January 27, 2022
Baicalein inhibits macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα pathway.
Journal: Clinical and experimental immunology
Published: November 28, 2021
Endocan: A Key Player of Cardiovascular Disease.
Journal: Frontiers in cardiovascular medicine
Published: October 20, 2021
C1q Tumor Necrosis Factor-Related Protein 1: A Promising Therapeutic Target for Atherosclerosis.
Journal: Journal of cardiovascular pharmacology
Published: September 15, 2021
Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis.
Journal: Aging and disease
Published: September 14, 2021
Last Updated: 09/26/2026